Home Articles List Article Information
The Egyptian Journal of Hospital Medicine
Journal Archive
Volume Volume 97 (2024)
Volume Volume 96 (2024)
Volume Volume 95 (2024)
Volume Volume 94 (2024)
Volume Volume 93 (2023)
Volume Volume 92 (2023)
Volume Volume 91 (2023)
Volume Volume 90 (2023)
Volume Volume 89 (2022)
Volume Volume 88 (2022)
Volume Volume 87 (2022)
Volume Volume 86 (2022)
Volume Volume 85 (2021)
Volume Volume 84 (2021)
Volume Volume 83 (2021)
Volume Volume 82 (2021)
Volume Volume 81 (2020)
Volume Volume 80 (2020)
Volume Volume 79 (2020)
Volume Volume 78 (2020)
Volume Volume 77 (2019)
Volume Volume 76 (2019)
Volume Volume 75 (2019)
Volume Volume 74 (2019)
Volume Volume 73 (2018)
Volume Volume 72 (2018)
Volume Volume 71 (2018)
Volume Volume 70 (2018)
Volume Volume 69 (2017)
Volume Volume 68 (2017)
Volume Volume 67 (2017)
Volume Volume 66 (2017)
Volume Volume 65 (2016)
Volume Volume 64 (2016)
Volume Volume 63 (2016)
Volume Volume 62 (2016)
Volume Volume 61 (2015)
Volume Volume 60 (2015)
Volume Volume 59 (2015)
Volume Volume 58 (2015)
Volume Volume 57 (2014)
Volume Volume 56 (2014)
Volume Volume 55 (2014)
Volume Volume 54 (2014)
Volume Volume 53 (2013)
Volume Volume 52 (2013)
Volume Volume 51 (2013)
Volume Volume 50 (2013)
Volume Volume 49 (2012)
Volume Volume 48 (2012)
Volume Volume 47 (2012)
Volume Volume 46 (2012)
Volume Volume 45 (2011)
Volume Volume 44 (2011)
Volume Volume 43 (2011)
Volume Volume 42 (2011)
Volume Volume 41 (2010)
Volume Volume 40 (2010)
Volume Volume 39 (2010)
Volume Volume 38 (2010)
Volume Volume 37 (2009)
Volume Volume 36 (2009)
Volume Volume 35 (2009)
Volume Volume 34 (2009)
Volume Volume 33 (2008)
Volume Volume 32 (2008)
Volume Volume 31 (2008)
Volume Volume 30 (2008)
Volume Volume 29 (2007)
Volume Volume 28 (2007)
Volume Volume 27 (2007)
Volume Volume 26 (2007)
Volume Volume 25 (2006)
Volume Volume 24 (2006)
Volume Volume 23 (2006)
Volume Volume 22 (2006)
Volume Volume 21 (2005)
Volume Volume 20 (2005)
Volume Volume 19 (2005)
Volume Volume 18 (2005)
Volume Volume 17 (2004)
Volume Volume 16 (2004)
Volume Volume 15 (2004)
Volume Volume 14 (2004)
Volume Volume 13 (2003)
Volume Volume 12 (2003)
Volume Volume 11 (2003)
Volume Volume 10 (2003)
Volume Volume 9 (2002)
Volume Volume 8 (2002)
Volume Volume 7 (2002)
Volume Volume 6 (2002)
Volume Volume 5 (2001)
Volume Volume 4 (2001)
Volume Volume 3 (2001)
Volume Volume 2 (2001)
Volume Volume 1 (2000)
(2024). Low-Dose Aspirin in Combination with Transarterial Chemoembolization in Treatment of Unresectable Hepatocellular Carcinoma. The Egyptian Journal of Hospital Medicine, 94(1), 18-22. doi: 10.21608/ejhm.2024.334358
. "Low-Dose Aspirin in Combination with Transarterial Chemoembolization in Treatment of Unresectable Hepatocellular Carcinoma". The Egyptian Journal of Hospital Medicine, 94, 1, 2024, 18-22. doi: 10.21608/ejhm.2024.334358
(2024). 'Low-Dose Aspirin in Combination with Transarterial Chemoembolization in Treatment of Unresectable Hepatocellular Carcinoma', The Egyptian Journal of Hospital Medicine, 94(1), pp. 18-22. doi: 10.21608/ejhm.2024.334358
Low-Dose Aspirin in Combination with Transarterial Chemoembolization in Treatment of Unresectable Hepatocellular Carcinoma. The Egyptian Journal of Hospital Medicine, 2024; 94(1): 18-22. doi: 10.21608/ejhm.2024.334358

Low-Dose Aspirin in Combination with Transarterial Chemoembolization in Treatment of Unresectable Hepatocellular Carcinoma

Article 4, Volume 94, Issue 1, January 2024, Page 18-22  XML PDF (542.24 K)
DOI: 10.21608/ejhm.2024.334358
View on SCiNiTO View on SCiNiTO
Abstract
Background: Various strategies under investigation aim to improve the outcome of transarterial chemoembolization (TACE). Aspirin demonstrated chemopreventive, antithrombotic and anti- inflammatory properties. Moreover, it has been reported that aspirin may reverse apoptosis resistance in hepatocellular carcinoma (HCC) cell lines.
Objective: To explore the clinical impact of adding aspirin with TACE in management of unresectable HCC patients.
Patients and Methods: This prospective randomized trial included 60 cases diagnosed as HCC indicated for TACE; who were simply randomized into two arms with ratio 1:1; to control arm and aspirin arm. Aspirin arm patients received 75 mg of aspirin daily for 3 months; we assessed aspirin toxicity and disease outcome.
Results: In this study most of side effects of aspirin were of grade I gastrointestinal side effect. 10% of patients in aspirin arm had complete response versus 6.7 % in control arm and 30% had partial response in aspirin arm versus 23% in control arm, 30% of patients in aspirin arm had disease progression versus 40% in control arm. The median progression free survival and Overall survival were not reached for aspirin arm versus 11 and 22 months for control arm (P=0.035 and P=0.036 respectively).
Conclusions: Low dose aspirin use in selected unresectable intermediate stage HCC undergoing TACE is tolerable and could be associated with survival benefit.
Statistics
Article View: 123
PDF Download: 242